Nutrien (NTR)

• Market cap: $21.9B
• 1 day: -0.18%
• 5 days: -1.51%
• 1 month: -3.22%
• 3 months: -8.71%
• 6 months: -14.82%
• Year to date: -22.11%
• 1 year: -22.57%
• 5 years: -9.18%
• 10 years: -18.87%

About: Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

Employees: 25,900

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0.77% less ownership

Funds ownership: 65.95% [Q2] → 65.18% (-0.77%) [Q3]

7% less repeat investments, than reductions

Existing positions increased: 203 | Existing positions reduced: 219

6% less funds holding

Funds holding: 618 [Q2] → 583 (-35) [Q3]

7% less capital invested

Capital invested by funds: $16.7B [Q2] → $15.5B (-$1.15B) [Q3]

33% less funds holding in top 10

Funds holding in top 10: 15 [Q2] → 10 (-5) [Q3]

36% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 98

43% less call options, than puts

Call options by funds: $225M | Put options by funds: $392M

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $51 15% upside
• Avg. target: $57 27% upside
• High target: $60 35% upside

4 analyst ratings

• positive: 3 75%
• neutral: 1 25%
• negative: 0 0%

Oppenheimer Kristen Owen 35% 1-year accuracy 11 / 31 met price target	35% upside $60	Outperform Initiated	12 Dec 2024
CIBC	24% upside $55	Outperformer Assumed	10 Dec 2024
Raymond James Steve Hansen 50% 1-year accuracy 1 / 2 met price target	35% upside $60	Outperform Upgraded	3 Dec 2024
UBS Joshua Spector 37% 1-year accuracy 14 / 38 met price target	15% upside $51	Neutral Downgraded	10 Oct 2024